Back
Open Access

Vutrisiran in ATTR-CM: transforming outcomes with precision medicine

logo

Session: RNAi therapeutics: changing the future landscape in ATTR-CM management
Topic: Cardiac Amyloidosis
Speaker: Doctor C. Morbach (Wuerzburg, DE)
Sponsored by Alnylam Pharmaceuticals
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Caroline Morbach

University Hospital Wuerzburg, Wuerzburg (Germany)
2 presentations
0 follower

3 more presentations in this session

Welcome and introductions

Speaker: Doctor E. Gonzalez Lopez (Madrid, ES)

Access
Like
Thumbnail

RNAi therapeutics: revolutionising cardiovascular management

Speaker: Doctor S. Cuddy (Boston, US)

Access
Like
Thumbnail

Ask the experts – panel discussion and audience Q&A

Access
Like
Thumbnail

Access the full session

RNAi therapeutics: changing the future landscape in ATTR-CM management

Speakers: Doctor C. Morbach, Doctor E. Gonzalez Lopez, Doctor S. Cuddy
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources